CDMO Partnerships

Overview

Contract development and manufacturing relationships central to advanced modality programs; frequently fail due to incentive misalignment, insufficient modality-specific expertise, and absence of risk-sharing or transparency. CDMO partnerships for advanced modalities frequently fail because CDMOs are incentivized to fill manufacturing suites rather than develop genuine expertise in the specific modality required, creating capability and incentive misalignment at the outset. Panelists advocate reframing CDMO relationships from client-vendor transactions to patient-centered collaborations where the CDMO thinks about getting effective drugs to patients rather than filling capacity slots. (Segment 4 (15:00-20:00))